Cite
HARVARD Citation
Davis, K. et al. (2021). Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial. Lancet infectious diseases. 21 (5), pp. 688-696. [Online].